Key result
Warfarin therapy management for patients with INR ≥6.0 revealed multiple difficulties in 30 of 40 patients, with 16 of 36 treating doctors deferring total responsibility to the pathology provider.
Cross-Sectional (n=76)
No
There is a significant lack of role clarity and communication between doctors and pathology services in managing warfarin therapy, highlighting the need for improved coordination and patient assessment.
No takes yet. Share an insight, caveat, or question.
May indicate safety risks from unclear warfarin roles; leaves open whether clarifying responsibilities improves outcomes.
Lowthian et al. (2009) conducted a cross-sectional in Warfarin therapy with INR ≥ 6.0 (n=76). Warfarin therapy management was evaluated on Patients' demographic, clinical, cognitive and psychosocial characteristics, warfarin knowledge, medication complexity and adherence; and doctors' experience with, approach to and involvement in warfarin management. Warfarin therapy management for patients with INR ≥6.0 revealed multiple difficulties in 30 of 40 patients, with 16 of 36 treating doctors deferring total responsibility to the pathology provider.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: